Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $7.65 USD
Change Today +0.09 / 1.19%
Volume 2.8M
SGMO On Other Exchanges
SGMO is not on other exchanges.
As of 8:10 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Edward O. Lanphier II

Founder, Chief Executive Officer, President, Director and Member of Clinical Review Committee,Sangamo Biosciences Inc.
AgeTotal Calculated CompensationThis person is connected to 143 board members in 5 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Edward O. Lanphier, II, founded Sangamo BioSciences Inc. and has been its President and Chief Executive Officer since 1995. Mr. Lanphier has been the Chairman of Executive Committee at Alliance for Regenerative Medicine since December 31, 2014. From June 1992 to May 1997, Mr. Lanphier served in various positions with Somatix Therapy Corporation, including Executive Vice President of Commercial Development and Chief Financial Officer. He served as the President and ...

Read Full Background

Corporate Headquarters*

501 Canal Boulevard
Richmond, California 94804

United States

Phone: 510-970-6000
Fax: 510-236-8951

Board Members Memberships*

Founder, Chief Executive Officer, President, Director and Member of Clinical Review Committee


Knox College

Other Affiliations*

Annual Compensation*

Total Annual Compensation$650,000

Stock Options*

Restricted Stock Awards$1,758,750
Exercised Options300,000
Exercised Options Value$3,442,735
Exercisable Options1,562,500
Exercisable Options Value$13,253,375
Unexercisable Options487,500
Unexercisable Options Value$1,857,625
Total Value of Options$18,553,735
Total Number of Options2,350,000

Total Compensation*

Total Annual Cash Compensation$1,001,000
Total Short Term Compensation$650,000
Other Long Term Compensation$1,758,750
Total Calculated Compensation$4,784,225
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SGMO:US $7.65 USD +0.09


Nick Leschly Chief Executive Officer, President and Director
bluebird bio, Inc.
André Choulika Ph.D.Co-Founder, Chairman and Chief Executive Officer
Cellectis S.A.
David M. Pernock Chairman, Chief Executive Officer and President
Fibrocell Science, Inc.
Jörn Aldag Chief Executive Officer, Managing Director and Member of Management Board
uniQure N.V.
Jeffrey D. Marrazzo M.B.A., M.P.A.Co-Founder, Chief Executive Officer and Director
Spark Therapeutics, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SANGAMO BIOSCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at